Modulations of genes related to gut integrity, apoptosis, and immunity underlie the beneficial effects of Bacillus amyloliquefaciens CECT 5940 in broilers fed diets with different protein levels in a necrotic enteritis challenge model
The ban of in-feed antimicrobial additives has negatively affected the poultry industry by causing necrotic enteritis (NE) to emerge in the flocks. Alternatives such as probiotics have shown to be effective on eliminating the negative effects of this disease. Two experiments were conducted to invest...
Gespeichert in:
Veröffentlicht in: | Journal of Animal Science and Biotechnology 2020-10, Vol.11 (1), p.104-13, Article 104 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The ban of in-feed antimicrobial additives has negatively affected the poultry industry by causing necrotic enteritis (NE) to emerge in the flocks. Alternatives such as
probiotics have shown to be effective on eliminating the negative effects of this disease. Two experiments were conducted to investigate the effect of
CECT 5940 (BA) in broiler chickens under NE challenge and/or fed diets with different protein levels.
In both experiments, 480 day-old mix-sexed Ross-308 broilers were arranged in a 2 × 2 factorial arrangement of treatments. In experiment 1, the factors were NE challenge (yes or no) and probiotic (yes or no). In experiment 2, the factors were dietary crude protein levels (standard or reduced) and probiotic (yes or no) and were used under NE challenge condition. Oral administration of
oocysts (day 9) followed by inoculation with
(day 14 and 15) was used to induce NE challenge. On day 16, two birds from each treatment were gavaged with fluorescein isothiocyanate-dextran (FITC-d) and blood samples were collected for gut integrity evaluation, and jejunal samples were collected for gene expression assay.
In experiment 1, BA supplementation decreased caspase-3 (
) (
< 0.001) and caspase-8 (
) (
|
---|---|
ISSN: | 1674-9782 2049-1891 2049-1891 |
DOI: | 10.1186/s40104-020-00508-4 |